Internal Medicine (Theory) · MU Sofia

48. Acute leukemia

Covers the two main types of acute leukaemia, lymphoblastic and myeloid, outlining their causes, the pancytopenia and infiltration behind their symptoms, and how they are diagnosed through blood counts, marrow findings, immunophenotyping and cytogenetics. It closes with treatment strategies, supportive care and prognosis, with a child-versus-adult contrast running through the ALL and AML sections.

Inside: 12 sections · 4 labelled pictures · 16 flashcards · 4 min

Topic 45 of 58 in the MU Sofia syllabus for Internal Medicine (Theory) (Medicine, Year 3). The free AceMed note covers it in 12 sections, about 481 words (4 min of reading), with 16 flashcards.

In this note

  1. Acute Leukemia (AML & ALL)
  2. Definition:
  3. Classification:
  4. Etiology:
  5. Pathogenesis:
  6. Symptoms:
  7. Diagnosis:
  8. Laboratory Tests:
  9. Instrumental Tests:
  10. Treatment:
  11. Treatment Strategies:
  12. Prognosis:

Definition:

Acute leukemias are malignant neoplasms of hematopoietic progenitor cells characterized by:

  • Rapid proliferation of immature white blood cells (blasts)
  • Replacement of bone marrow with blasts
  • Sudden onset and fast progression

They are classified as either:

  • Acute Lymphoblastic Leukemia (ALL) – from lymphoid progenitors
  • Acute Myeloid Leukemia (AML) – from myeloid progenitors

Classification:

  • Acute Lymphoblastic Leukemia (ALL): More common in children
  • Acute Myeloid Leukemia (AML): Primarily affects adults; may arise de novo or from myelodysplastic syndromes

Etiology:

General Causes:

  • Radiation (e.g., therapeutic or environmental): Causes DNA damage to hematopoietic stem cells
  • Chemicals: Benzene exposure
  • Drugs: Cytotoxic chemotherapy (alkylating agents, topoisomerase inhibitors)
  • Viruses: Human T-cell lymphotropic virus type 1 (HTLV-1) → Adult T-cell leukemia
  • Genetics:
  • Down syndrome (especially predisposes to AML)
  • Fanconi anemia
  • Bloom syndrome
  • t(12;21), t(9;22) in ALL

AML-specific:

  • May develop secondary to:
  • Myelodysplastic syndrome (MDS)
  • Chemotherapy or radiation therapy

ALL-specific:

  • Most common in children (peak incidence: 2–5 years)

Pathogenesis:

  • Genetic mutations disrupt normal differentiation of hematopoietic stem cells
  • Blasts proliferate uncontrollably and infiltrate bone marrow, crowding out normal hematopoiesis
  • Leads to pancytopenia:
  • Anemia → ↓ RBCs
  • Leukopenia or non-functional leukocytosis → ineffective immune defense
  • Thrombocytopenia → bleeding tendencies
  • Blast cells may infiltrate:
  • Liver, spleen, lymph nodes (especially in ALL)
  • CNS, testes, skin (notably in ALL and AML variants)

Continue reading free

The whole note, all 12 sections, is free with an AceMed account, with its 16 flashcards. Premium adds flashcard recall, highlights and Ask AI.